Experiences with
Cyclophosphamide1,139 public posts
Want to take advantage of all our features? Just log in!
or
ASH 2013: Dr. Jeff Sharman Discusses FCR versus BR in CLL
Hi Friends
On my blog today http://bkoffman.blogspot.com I share my ASH interview with Dr. Sharman where we discussed the data on FCR versus BR.
While this is less the exciting news it would have been a few years back before the emerging era of targeted therapies,, it is still important for a significant
iwCLL 2013: Dr. Michael Hallek Discusses Clinical Trials in Germany versus the USA and BR versus FCR
Hi friends,
After a holiday break, I am back posting interviews about CLL on my blog: http://bkoffman.blogspot.com
I line the way Prof. Hallek thinks about these issues
Happy New Year to all.
Brian